China SXT Pharmaceuticals, Inc. (SXTC)
USD 2.28
(2.7%)
USD 2.28
(2.7%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -3.57 USD | 83.94% |
| 2023 | -22.23 USD | 83.88% |
| 2022 | -137.92 USD | -44.45% |
| 2021 | -95.48 USD | 88.53% |
| 2020 | -832.08 USD | -655.94% |
| 2019 | 149.67 USD | 29.61% |
| 2018 | - USD | 0.21% |
| 2017 | - USD | 737.5% |
| 2016 | - USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 2.67 USD | 127.61% |
| 2024 Q1 | -9.67 USD | -88.13% |
| 2024 Q4 | 2.67 USD | 0.0% |
| 2024 FY | - USD | 71.93% |
| 2024 Q2 | -9.67 USD | 0.0% |
| 2023 Q2 | -7.30 USD | 0.0% |
| 2023 Q4 | -5.14 USD | 0.0% |
| 2023 Q3 | -5.14 USD | 29.59% |
| 2023 Q1 | -7.30 USD | 71.25% |
| 2023 FY | - USD | 90.78% |
| 2022 Q1 | -49.71 USD | -126.95% |
| 2022 Q4 | 44.58 USD | 275.58% |
| 2022 Q2 | -74.34 USD | -49.55% |
| 2022 Q3 | -25.39 USD | 65.85% |
| 2022 FY | - USD | -44.45% |
| 2021 Q3 | -71.73 USD | -398.88% |
| 2021 Q4 | 184.47 USD | 357.17% |
| 2021 FY | - USD | 88.53% |
| 2021 Q2 | 24.00 USD | 0.0% |
| 2021 Q1 | 24.00 USD | 103.12% |
| 2020 Q2 | -189.91 USD | -83.81% |
| 2020 Q3 | -297.04 USD | -56.41% |
| 2020 FY | - USD | -655.94% |
| 2020 Q1 | -103.32 USD | -171.59% |
| 2020 Q4 | -769.76 USD | -159.14% |
| 2019 Q1 | 48.38 USD | 173.64% |
| 2019 FY | - USD | 29.61% |
| 2019 Q3 | 25.51 USD | -73.64% |
| 2019 Q2 | 96.76 USD | 100.0% |
| 2019 Q4 | 144.33 USD | 465.78% |
| 2018 FY | - USD | 0.21% |
| 2018 Q3 | 97.79 USD | 155.46% |
| 2018 Q4 | 17.68 USD | -81.92% |
| 2018 Q1 | 38.28 USD | 5.02% |
| 2018 Q2 | 38.28 USD | 0.0% |
| 2017 Q4 | 36.45 USD | 0.0% |
| 2017 FY | - USD | 20117.54% |
| 2016 FY | - USD | 0.0% |